Prudential Financial’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Prudential Financial’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-145,435	Closed	-$2.9M	–	2753
2022 Q3	$2.9M	Buy	145,435 +38,300	+36%	+$505K	﹤0.01%	1115
2022 Q2	$738K	Buy	+107,135	New	+$752K	﹤0.01%	1939

Prudential Financial's FMTX Position: Q4 2022 in Review

Prudential Financial sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 145,435 shares — an estimated $2.9M sold.

Prudential Financial first reported a position in FMTX in Q2 2022 and held it in 2 quarters. The position peaked at $2.9M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Prudential Financial reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Prudential Financial sold 145,435 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $2.9M.
Prudential Financial first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Prudential Financial's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.9M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.